HOXB4 overexpression mediates increased self-renewal of haematopoietic stem cells (HSCs) ex vivo. Since HOXB4-expanded HSCs retain normal differentiation potential and there is no leukaemia development from transduced HSCs, HOXB4 represents a promising tool for human HSC therapy. However, the increased proliferation capacity of HOXB4 overexpressing fibroblasts resulting from upregulation of JunB, Fra-1 and cyclin D1 protein levels may indicate a potential risk associated with the HOXB4 overexpression approach. This prompted us to investigate the proliferation rate, differentiation and expression of cell cycle regulators directly in bone marrow cultures overexpressing HOXB4. Here we show that in comparison to neo-transduced control bone marrow cultures, HOXB4-overexpressing cultures had a more homogenous morphology and increased numbers of haematopoietic progenitor cells capable to generate primitive colonies in vitro. In contrast, neo-transduced bone marrow cells in long-term cultures showed hallmarks of myeloid differentiation and a reduced secondary colony forming activity. We further show that multilineage repopulating activity in vivo, which was present only in HOXB4 long-term cultures, declined over time. HOXB4 overexpression in vitro did not result in an increase but in a stabilization of the proliferation rate (1.4-1.8 cell divisions per day), while the proliferation rate of control neo-transduced bone marrow cultures gradually declined. Correspondingly, increased HOXB4 expression was paralleled by decreased expression levels of cyclins, CDKs and AP-1 family members. These results suggest that the growth rate of HOXB4-compared to neotransduced bone marrow cells remains constant in longterm cultures along with a suppression of myeloid differentiation. In contrast to HOXB4 overexpression in fibroblasts, bone marrow cells engineered to overexpress HOXB4 do not upregulate AP-1 complex members or cyclins indicating that HOXB4 acts in a cell typespecific way.
Introduction
Self-renewal and multilineage differentiation are functional characteristics of stem cells (Loeffler and Roeder, 2002) . The presence of both characteristics distinguishes such rare cells from the majority of other cell populations. Haematopoietic stem cells (HSCs) are present in the adult bone marrow of mammals and provide the organism with lifelong haematopoiesis. A limited in vitro expansion of HSCs is possible by a variety of strategies such as coculture of HSCs with haematopoietic feeder cells (Moore et al., 1997; Oostendorp et al., 2002) , supplementation of media with fibroblast growth factor-1 (de Haan et al., 2003) , Wnt proteins (Murdoch et al., 2003; Willert et al., 2003) , Sonic hedgehog (Bhardwaj et al., 2001) , Thrombopoietin or a combination of different growth factors (Conneally et al., 1997; Ueda et al., 2000) . However, no protocol has been established for robust expansion of HSCs in vitro that achieves the more than 300-fold in vivo clonal amplification of a single transduced HSC (Pawliuk et al., 1996) . The only protocols that result in a robust HSC expansion utilized genetic manipulation of HSCs to selectively overexpress either MDR1 (Bunting et al., 1998) , Notch1 (VarnumFinney et al., 2000) or HOXB4 (Sauvageau et al., 1995; Thorsteinsdottir et al., 1999; Antonchuk et al., 2001 Antonchuk et al., , 2002 .
The homeobox transcription factor HOXB4 has emerged as an important and potent regulator of haematopoiesis (Sauvageau et al., 1995; Thorsteinsdottir et al., 1999; Antonchuk et al., 2001 Antonchuk et al., , 2002 . Enforced expression of HOXB4 in mouse bone marrow cells significantly enhances the regenerative potential of HSCs both in vitro and in serial transplantation models in vivo. As a consequence, HOXB4 overexpression results in a selective expansion of transduced HSCs. While the self-renewal capacity of HOXB4 overexpressing HSCs (HOXB4 HSCs) is increased, homeostatic control of HSC population size and the rate of production and maintenance of mature effector cells is not impaired. Thus, retrovirus mediated gene transfer of HOXB4 promotes the expansion of HSCs without altered lineage decisions or induction of leukaemia. As a consequence, temporal overexpression of HOXB4 and/or corresponding HOXB4 target genes could have enormous therapeutical potential for human HSCs. Indeed, high level HOXB4 expression conferred a profound in vivo competitive advantage on human cord blood CD34 þ cells (Schiedlmeier et al., 2002) . Moreover, recently, a more application-oriented approach revealed human and murine HSC expansion in vitro upon administering recombinant HOXB4 protein (Amsellem et al., 2003; Krosl et al., 2003) . However, HOXB4-mediated proliferation is dose dependent and high HOXB4 expression levels substantially impair differentiation of myelo/erythroid and B lineage cells (Buske et al., 2002; Schiedlmeier et al., 2002; Brun et al., 2003) .
Rather surprisingly, the underlying molecular mechanisms involved in HOXB4-dependent proliferation of HSCs have not been identified yet. Sauvageau and coworkers (Krosl et al., 1998; Krosl and Sauvageau, 2000) reported that the increased serum responsiveness and enhanced proliferation rate of HOXB4-overexpressing Rat-1 fibroblasts are correlated with a significant increase of AP-1 activity due to the upregulation of JunB and Fra-1 protein levels. It is also established that these specific changes converge to increase cyclin D1 levels. This result is not surprising, as cyclin D1 is a wellestablished regulator of the cell cycle that integrates proliferation signals from different signalling pathways (Sherr, 1993 (Sherr, , 1996 . However, cyclin D1 is a direct betacatenin target gene at least in colon cancer cells and upregulation of cyclin D1 is linked with a variety of malignancies (Rowlands et al., 2004) . JunB is an important regulator of cell proliferation and is suggested to play a role in the myeloid differentiation programme (Passegue and Wagner, 2000; Passegue et al., 2001) and in Hodgkin's lymphoma cells (Mathas et al., 2002) . Therefore, it remains to be shown whether the molecular mechanisms of HOXB4-dependent proliferation are cell type-specific and whether HOXB4 overexpression has similar consequences on murine bone marrow cells.
To address these questions we overexpressed HOXB4 via a retroviral vector in 5-fluorouracil (5-FU)-treated bone marrow cells and analysed the proliferation rate and the consequences of HOXB4 expression on differentiation and expression of cyclins, AP-1 complex members and CDKs. Our results indicate that the growth rate of HOXB4-compared to neo-transduced bone marrow cells is not increased, but rather remains constant in long-term cultures. Correspondingly, HOXB4 overexpression in bone marrow cells does not increase expression levels of typical proliferationassociated genes but diminishes myeloid differentiation in vitro.
Results

Proliferation and differentiation of bone marrow cells overexpressing HOXB4
To study the cellular and molecular consequences of HOXB4 we examined the effects of HOXB4 overexpression following retrovirus mediated gene transfer into 5-FU-treated murine adult bone marrow cells. 5-FU treatment eliminates rapidly dividing and committed progenitors in the bone marrow and therefore enriches for primitive haematopoietic progenitor cells (Randall and Weissman, 1997) . The overall experimental design is outlined in Figure 1a . For this study, the vector MSCV-HAHOXB4-neo, a modified version of a HOXB4 expression construct originally described by Humphries and co-workers, was employed ( Figure 1b) (Sauvageau et al., 1995) . Prior to transduction, mouse bone marrow cells were isolated from animals 4 days after injection of 5-FU. Isolated bone marrow cells were cultured for 2 days in medium supplemented with haematopoietic cytokines. Then, cells were transduced twice within 2 days with retroviral supernatants, and starting at 1 day post-transduction (dpt) cells were selected for 3 days in medium containing high concentration of G418. Virus infection efficiencies of 5-FU bone marrow cells with neo-and HOXB4-vectors were typically 10-20 and 20-30%, respectively. All noninfected cells were dead after 3 days of G418 selection as tested by mock transduction. Owing to the low cell numbers in 5-FU bone marrow, transgene expression was verified in human K562 cells. HOXB4 protein was detectable as a 33 kDa HA-tagged protein in Western blot analysis following transduction of K562 cells and subsequent G418 selection (Figure 1c ). Western blot analysis of K562 cells, untransduced or transduced with either neo or HOXB4 viruses, using a monoclonal anti-HA antibody. G418 selection was started at 2 dpt (days post transduction) and continued until all mock-transduced control cells had died, then lysates were prepared HOXB4 confers constant proliferation rate C Schmittwolf et al Next, we evaluated the effects of HOXB4 overexpression on progenitor and multilineage engrafting activities. In comparison with neo cultures, HOXB4 overexpression resulted in a moderate rise of primary colony forming cells (Figure 2a) . In semisolid media, HOXB4 cultures generated denser colonies with increased cell numbers per colony. To determine the proliferation potential of HOXB4 and neo colonies, whole cultures were harvested 7 days postplating and cells were reseeded in secondary methyl cellulose cultures. In accord with previously published data, we found that cells harvested from HOXB4 but not neo cultures showed a primitive morphology and generated considerably more secondary colonies (Sauvageau et al., 1995) .
Transplantations of HOXB4-and neo-transduced bone marrow cells at 11, 14 and 18 dpt into irradiated CD45 congenic recipient mice under competitive repopulation conditions revealed that HOXB4 but not neo cultures contained cells that engraft transplant recipients and generate CD45 þ donor cells in the peripheral blood of recipient animals that coexpressed CD3, CD19 or Mac-1 (Figure 2b and c). However, engraftment potential decreased during prolonged culture, as 11 dpt HOXB4 cells generated higher chimerism in transplant recipients compared to 18 dpt HOXB4 cells (Figure 2b ). This confirms the biological activity of retrovirally transduced HOXB4 by demonstrating enhanced progenitor activity in vitro and haematopoietic engraftment after ex vivo culture as previously reported (Antonchuk et al., 2002) .
Recent reports described the growth-enhancing effects of HOXB4 on Rat-1 fibroblasts and bone marrow cells (Krosl and Sauvageau, 2000; Antonchuk et al., 2001) . To characterize the consequence of HOXB4 overexpression on bone marrow cells, we first determined the growth of total cells in culture. As shown in Figure 3a , HOXB4 overexpression gave a continuing increase in cell numbers, while cell numbers in neo cultures declined after a phase of expansion. Next, we determined the level of proliferation and its rate using a 3 H-thymidine incorporation assay. Comparable 3 H-thymidine incorporation levels in cultures transduced with neo-or HOXB4-vectors were observed at early time points (at 5-7 dpt), indicating similar numbers of proliferating cells. In contrast, when cultures were analysed later at 9-11 dpt, HOXB4-transduced cells showed markedly increased proliferation compared to neo-transduced bone marrow cells (Figure 3b ). Both HOXB4 and neo cultures at 9 and 10 dpt revealed lower proliferation than corresponding cultures analysed at 5-7 dpt ( Figure 3b , left and right), in accord with published results (Antonchuk et al., 2002) . However, this type of analysis only measures the relative proportion of dividing cells but does not determine the rate of proliferation. To analyse the proliferation rate in neoand HOXB4-transduced bone marrow cultures, aliquots of nonadherent cells from a culture that was maintained for a total of 23 days were plated every second day into fresh medium, and the relative proliferation within 24 h was determined by calculating the quotient of 3 H-thymidine incorporation at 48 and 24 h postseeding. As shown in Figure 3c (top, left), the proliferation rate of HOXB4-and neo-transduced bone marrow cells was similar early after transduction. However, while the proliferation rate of HOXB4-transduced cultures remained constant within the tested time frame, the proliferation rate in neo-transduced control cultures steadily declined. The slope of trend lines calculated for HOXB4 cultures was typically around 0. The trend line typically intercepted the y-axis with a value around 1.7, indicating a constant 1.7-fold increase in cell numbers in a 24 h interval during long-term cultivation. In contrast, neo cultures were characterized by a negative slope and a Y value of approximately 2, indicating a two-fold increase in cell number at 3 dpt but a decline in proliferation rate at later time points. When proliferation rates of neo and HOXB4 cultures were determined on the basis of cell numbers by trypan blue dye exclusion staining over a period of 23 days, similar trend line profiles were observed ( Figure 3c , bottom, left). In neo-but not in HOXB4-transduced cultures, most cells became adherent within approximately 13 days, so not enough cells could be collected at later time points for analysis. The differences in proliferation rates in both cultures were even more pronounced when HOXB4-and neo-transduced cells were maintained under differentiation conditions in medium supplemented with GM-CSF and IL3 ( Figure 3c , right panels). Thus, under both culture conditions HOXB4 overexpressing cells maintained a constant proliferation rate while in control neo cultures the rate of proliferation declined over time.
To investigate whether all cells divide in neo-and HOXB4-transduced cultures, the fluorescence profiles of CFSE-labelled cells were determined (Lyons and Parish, 1994) . The distribution of cells according to their CFSE fluorescence indicated that the great majority of HOXB4-transduced bone marrow cells divide in liquid cultures ( Figure 3d ). After 48 h in culture, almost all HOXB4 cells proliferated. Some cells completed up to six cell divisions (7 dpt, IL3, IL6, SCF). The majority of cells completed 3-5 cell divisions, with the mean peak at four divisions. In neo cultures a significant proportion of cells maintained CFSE label, in particular under myeloid differentiation conditions, further indicating decreased cell division and differentiation. Taken together, these results indicate that HOXB4 overexpression does not lead to an increase in the proliferation rate of bone marrow cells; instead, the growth rate of HOXB4 cells is stabilized and stays constant in longterm cultures, while the growth rate of neo-transduced cultures declines.
To assess the influence of HOXB4 overexpression on in vitro differentiation, we analysed the morphology and immune phenotype of transduced bone marrow cells. Cells in neo-transduced cultures frequently displayed differentiated morphology, similar to nontransduced cultures. In contrast, cells from HOXB4 cultures developed a more monotonous and blastic morphology with hyperchromatic nuclei (Figure 4 ). In FACS analyses, cultures transduced with neo vectors generated (Figure 5d ). Finally, the frequency of dead cells in both cultures following G418 selection was below 30%, as determined by 7-AAD staining. These data show a decreased tendency of myeloid differentiation in HOXB4 overexpressing cultures.
Transcription of cyclins, AP-1 family members and CDKs in bone marrow cultures overexpressing HOXB4
To elucidate the molecular basis of cell cycle regulation in HOXB4-transduced bone marrow cultures, neo-and HOXB4-transduced cultures were analysed for the expression of cell cycle regulators. HOXB4-induced proliferation of Rat-1 fibroblasts was shown to be associated with increased DNA-binding activity of AP-1 and increased levels of cyclin D1 (Krosl and Sauvageau, 2000) . To ask whether the same mediators of cell proliferation are affected by HOXB4 overexpression in bone marrow cells, we employed an RNAse protection assay. The expression levels of the G 1 /S-cyclins D1, D2, D3, E, the S-cyclin A2 and the M-cyclins B1, B2 differed in HOXB4 and neo cultures ( Figure 6 ). In parallel with the accumulation of differentiated cells an increase in G 1 /S-cyclin transcripts was observed in neo cultures. On the contrary, G 1 /S-cyclin transcript levels in HOXB4 cultures remained at similar levels (cyclin D1, D2, D3) or the levels decreased (cyclin E). Finally, S-and M-cyclins were expressed at comparable levels in both HOXB4 and neo cultures. There were no detectable differences between neo-and HOXB4-transduced cultures in the expression levels of cyclins C, F, G1, G2 and H, while cyclin A1 and I transcripts were not detected.
The AP-1 family protein c-Jun acts as a proliferationpromoting transcription factor and is involved in cell cycle progression (Shaulian and Karin, 2001 ). Consequently, c-Jun expression level would be expected to increase if HOXB4 overexpression would increase proliferation rate of bone marrow cells. Our results show that fra-1 and fosB transcripts were not detectable in neo or HOXB4-transduced bone marrow cells. All other AP-1 family members, including c-Jun, revealed an increased expression level in neo-transduced cultures compared to HOXB4 cultures. HOXB4-transduced cultures produce relatively constant transcript levels of AP-1 complex members with little change in expression levels over time. Unlike transcripts of cyclins and AP-1 members, the general trend of CDK1, 2, 4, 5, 7 and 8 transcripts indicates similar and constant expression levels of CDK expression in neo-and HOXB4 long-term cultures (data not shown).
In summary, transcript levels of cyclins, AP-1 members and CDKs remain at a constant level in HOXB4 overexpressing cultures while in neo-transduced cells the level of these transcripts is upregulated in parallel to myeloid differentiation. These results support our conclusion that HOXB4 overexpression in fibroblasts and bone marrow cells results in different biological effects, specified by increased versus stabilized proliferation, respectively.
Discussion
In the present study, we investigated the ability of HOXB4 to affect proliferation and differentiation of murine bone marrow cells in vitro. Our results demonstrate that overexpression of HOXB4 does not increase but rather stabilizes the rate of proliferation of bone marrow cultures over several weeks. Concomitantly, differentiation is reduced in HOXB4 but not in control cultures. Correspondingly, expression levels of cyclins, CDKs and AP-1 family members are decreased in HOXB4 cultures in contrast to the neo-transduced cultures, which upregulate these cell-cycle regulators during extended ex vivo culture. 4 nonadherent cells each from a mother culture and maintained for 1-3 successive days (5-7 dpt, left panel). In parallel, a culture was maintained till 8 dpt when subcultures were started in triplicates each containing 5 Â 10 4 nonadherent cells that were also maintained for 1-3 successive days (9-11 dpt, right). To evaluate proliferation the subcultures were supplemented with 3 H-thymidine, and at various times, cells were transferred onto glass fibre filters, and filters were dried and counted by liquid scintillation. Mean and standard deviations are indicated. Representative analyses are shown (n ¼ 3). (c) Starting at 4 dpt, two sets of triplicates of 5 Â 10 4 nonadherent cells each from a mother culture supplemented with IL3, IL6 and SCF (left panels) or from a culture supplemented with GM-CSF and IL3 (right panels) were seeded every second day into fresh medium. H-thymidine incorporation (upper panels) and viable cell counts (lower panels) were determined from one set at 24 h and from the second set at 48 h postseeding. To determine the relative proliferation rate within 24 h, the ratios of 48 to 24 h values for 3 H-thymidine incorporation or viable cell counts were calculated and plotted for each time point. The relative proliferation rate was determined for cultures initiated with HOXB4-or neo-transduced cells as indicated. Trend lines were estimated using Microsoft Excel software, and the mathaematical equations f(x) are indicated (f 1 (x): relative proliferation of HOXB4-transduced cells; f 2 (x): relative proliferation of neo-transduced cells). Note that from day 13 onwards, the majority of the neo-transduced cells were adherent and no cells could be collected for analysis. 
Proliferation rate in HOXB4-transduced bone marrow cells
Earlier analysis revealed that HOXB4 cultures are characterized by an enhanced rate of growth of total cells and progenitors and a faster population doubling time (Antonchuk et al., 2001 (Antonchuk et al., , 2002 . Importantly, HSC numbers rapidly increased in cells engineered to express HOXB4 to a net of 41-fold HSC expansion over 14 days, while control cultures experienced a constant decrease in HSC content. Considering the loss of HSCs over time seen in control cultures, it appears that HOXB4 cultures attain up to a 1000-fold expansion of HSCs in primary and secondary recipients (Antonchuk et al., 2001 (Antonchuk et al., , 2002 . Analysis of the proliferation rates (Figure 3 ) revealed that HOXB4 transduced cells proliferate at a constant rate of about 1.4-1.8 cell divisions per day. This value represents the mean cell division rate for the entire cell population. The CFSE labelling data indicate that in HOXB4 cultures almost all cells proliferated within 2 days, and that the majority of cells completed 3-5 cell cycles. The whole population divided on average about four times per 48 h. This value is close to the proliferation rate of 1.4-1.8 divisions per day determined in our proliferation rate analyses. Importantly, similar proliferation profiles were reported when freshly isolated, nonmanipulated murine bone marrow cells were analysed by the CFSE labelling approach (Oostendorp et al., 2000) .
Former analysis of HOXB4-transduced bone marrow cells together with studies on HOXB4-overexpressing Rat-1 fibroblasts were interpreted as evidence of an enhanced proliferation of HOXB4-compared to neo-transduced cells (Krosl and Sauvageau, 2000; Antonchuk et al., 2001) . However, our data indicate cell type-specific effects of HOXB4 overexpression. Neoand HOXB4-transduced total bone marrow cultures do not significantly differ in their proliferation rates at early time points of expansion, either when probed by 3 Hthymidine incorporation or by directly quantifying cell numbers. Only when proliferation rates were studied over a longer time period did it appear that neo, in contrast to HOXB4, cultures experienced a decline in proliferation rate. Neo cultures accumulated differentiated cell types with extended culture time. This effect was enhanced when neo cultures were supplemented with GM-CSF and IL3 instead of IL3, IL6 and SCF as growth factors. Although these cultures are composed of heterogeneous cell types, our results indicate that HOXB4 overexpression results in maintenance of a constant rate of proliferation of transduced bone marrow cells and suggest the same for repopulating HSCs, which are a minor cell population in HOXB4-cultures. Thus, unlike Rat-1 fibroblasts, HOXB4-transduced bone marrow cells do not show an enhanced proliferation rate compared to control cultures, instead their proliferation rate remains constant.
Differentiation in HOXB4-transduced bone marrow cells
At the early stages of ex vivo expansion both HOXB4-and neo-transduced bone marrow cells expressed myeloid differentiation markers. Following transduction and selection, the morphology of cells in long-term HOXB4-overexpressing cultures showed a gradual stabilization, resulting in a more homogeneous cell population with a primitive phenotype. In contrast, cells in extended neo cultures showed hallmarks of myeloid differentiation. Consistent with the changes in morphology neo cultures generated cells that become strongly Mac-1 þ and Gr-1 þ , indicative of granuloid differentiation. In contrast, in HOXB4 cultures the frequency of cells expressing granuloid markers declined. HOXB4 cultures accumulated cells with low levels of Mac-1 expression. Thus, while HOXB4 overexpression does not inhibit haematopoietic differentiation in vivo, as evidenced by normal recovery and maintenance of all haematopoietic cell lineages (Antonchuk et al., 2001) , HOXB4 clearly interferes with haematopoietic differentiation of bone marrow cultures. This indicates that bone marrow microenvironment confers differentiation signals to HOXB4-transduced cells that are missing in in vitro cultures, and thus the bone marrow environment is able to override the HOXB4-mediated decrease of differentiation.
Interestingly, HSCs isolated from 5-FU-treated mice show low levels of Mac-1 and no/low c-kit expression (Randall and Weissman, 1997) . It thus seems possible that HSCs in HOXB4 cultures have a similar immune phenotype, with low Mac-1 and downregulation of c-kit, like HSCs from 5-FU-treated mice. Together the data are consistent with a scenario in which HOXB4 long-term cultures experience a reduced rate of myeloid differentiation as compared to neo control cultures. 3 ) and corresponding chloracetate esterase cytospin stainings (panels 2,4) of 11 dpt neo (panels 1,2) and HOXB4 cultures (panels 3,4). Metachromatic granules are indicative for mast cells (panel 1), orange staining indicates granulocytic differentiation (panels 2,4). Magnification: Â 500 (panels 1,3) or Â 400 (panels 2,4), respectively HOXB4 confers constant proliferation rate C Schmittwolf et al Figure 6 Expression of cyclins and AP-1 family members. HOXB4-and neo-transduced 5-FU bone marrow cells were selected for 3 days in G418 and grown till 24 dpt in medium containing IL3, IL6 and SCF. (a) RNA was prepared from aliquots taken at the indicated time points and subjected to RNA protection assays specific for different cyclins. Protected fragments were separated electrophoretically in urea-containing polyacrylamide gels; representative autoradiographs are displayed. (b) Relative expression levels of indicated transcripts were determined with a PhosphoImager and ImageQuant software using the expression of house keeping genes as internal controls. Values were plotted against time HOXB4 confers constant proliferation rate C Schmittwolf et al Different cyclin/CDK complexes function during distinct cell cycle stages and propel cell cycle progression by phosphorylation of specific substrates (Sherr, 1996; Israels and Israels, 2001 ). Cell cycle entry at G1/S depends on the formation of cyclin/CDK complexes, whereby D-type cyclins complex with CDK4 or CDK6, and cyclin E complexes with CDK2. Next, entry into S phase requires activation of a cyclinA/CDK2 complex while G2/M phase transition is initiated by a mitotic CDK complex consisting of cyclin B/p34cdc2. D-type cyclins operate as growth factor sensors that are induced by a variety of signals in a cell type-specific manner (Sherr, 1993) . For example, CD34 þ human bone marrow cells express CDKs and cyclins very weakly or expression is undetectable, with the exception of CDK4. In contrast, myeloid cells express cyclin D1, megakaryocytes show expression of cyclin D3 (Wang et al., 1995) , and in erythroid cells cdc2 and cyclin A plus CDK2 and cyclins D3 and E are elevated (Furukawa, 2002) . In addition, cyclins D3 and E are associated with terminal erythroid differentiation of cord blood cells (Dai et al., 2000) .
Consistent with the reports describing the expression of cyclin D1 in myeloid cells, we observed the upregulation of D-type cyclin transcripts in neo cultures at time points when cultures accumulate high numbers of differentiated cells. Our data show that several cyclins and CDKs are expressed in HOXB4 bone marrow cultures. However, when compared to neo cultures HOXB4 cultures do not upregulate cyclins, CDKs or AP-1 members. On the contrary, transcript levels of cyclins, CDKs and AP-1 complex proteins are maintained at similar levels or are rather decreased in longterm cultures of HOXB4-transduced cells. These data consolidate our findings that the proliferation rate in vitro of HOXB4-overexpressing bone marrow progenitor cells is not increased.
Low-level expression of cyclins and AP-1 members contrasts with an earlier observation made in HOXB4-transduced fibroblasts, where Fra-1 and JunB protein levels are significantly upregulated. These changes result in an increased cyclin D1 expression level that is necessary for HOXB4-mediated proliferation effects in fibroblasts (Krosl and Sauvageau, 2000) . Our observation that junB is upregulated in neo cultures during differentiation when proliferation declines is in agreement with the impaired proliferation of junB overexpressing fibroblasts (Passegue and Wagner, 2000) . Lack of cyclin D1 upregulation in HOXB4 cultures is in accordance with the lack of leukaemia originating from HOXB4 HSCs (Sauvageau et al., 1995; Antonchuk et al., 2002) .
Our analysis indicates that HOXB4 overexpression results in a temporary maintenance and expansion of engrafting potential that is paralled by a constant proliferation rate and stabilized expression of certain cyclins, CDKs and AP1 family members. We also observe that the expression of some factors such as cyclin A2, B1, B2 and E decreases. It remains to be shown how these changes reflect the gradual loss of engrafting potential in long-term HOXB4 cultures.
This study analysed HOXB4-and culture-induced phenotypic and molecular changes in entire HOXB4 cultures consisting of heterogeneous cell types. We did not directly determine the consequences of culture and HOXB4 expression in pure engrafting HSC populations as it is likely that the phenotype of engrafting HOXB4-expanded HSCs differs from freshly isolated HSCs. Manipulation of bone marrow by either cytotoxic agents such as 5-FU or in vitro culture induces phenotypic and functional changes to HSCs. Randall and Weissman (1997) showed that following 5-FU treatment long-term reconstituting HSCs decrease expression of c-kit by 10-fold and increase expression of Mac-1. Spangrude et al. (1995) reported that long-term repopulation of irradiated mice with purified HSCs resulted in an in vivo expansion of stem cell phenotype but not of function. Also, we show changes in phenotypes ( Figure 5 ) and engrafting potential (Figure 2 ) in long-term cultured cells. In consequence, the engrafting activity in HOXB4 cultures may not be associated with the lin À ckit þ , Sca1 þ phenotype. We expect, however, that changes in morphology, expression of cell surface and molecular markers in HOXB4 cultures mirror the changes in ex vivo expanded HSCs as HOXB4 bone marrow cells and stem/progenitor cells are closely related.
In summary, our data suggest that the underlying molecular mechanisms of HOXB4-associated proliferation control are cell type-specific and principally differ between fibroblasts, in which increased proliferation is observed, and bone marrow cells, in which retroviralmediated HOXB4 expression results in decreased myeloid differentiation, stabilization of proliferation and self-renewal of HSCs.
Materials and methods
Retroviral generation
The MSCV-HAHOXB4-neo retroviral vector was kindly provided to us by K Humphries (Terry Fox Laboratory, Vancouver, BC, Canada); the MSCV-neo control vector was a gift of B Schiedlmeier (Heinrich-Pette Institut, Hamburg, Germany). Viruses pseudotyped with the VSV-G envelope protein were produced by transient calcium phosphate cotransfection of amphotrophic Phoenix cells in a 10 cm dish with 12 mg retroviral vector DNA together with 12 mg plasmid DNA for gag-pol expression and 4 mg of a third plasmid encoding the VSV-G envelope protein (Schiedlmeier et al., 2002) . Cell culture supernatants were harvested 24, 36, 48, 60 and 72 h after transfection and stored in aliquots at À701C until use. Transduction efficiencies of 5-FU bone marrow cells with neo and HOXB4 vectors were in the range of 10-30%. After G418-selection (1.4 mg/ml), all mock-transduced cells died.
Transduction and culture of primary bone marrow cells and K562 cells
Bone marrow cells were obtained from C57Bl/6 CD45.1 mice that had received 4 days prior bone marrow isolation an intraperitoneal injection of 150 mg/kg body weight of 5-fluorouracil (Sigma) in PBS. After isolation of cells from femura and tibiae and erythrocyte lysis, cells were cultured for 48 h at a concentration of 1 Â 10 6 cells/ml in IMDM (20% FCS, 0.1% BSA, 10 ng/ml IL3, 20 ng/ml IL-6 and 50 ng/ml SCF). Following preculture, cells were transduced by adding retroviral supernatants and 4 mg/ml protamine sulphate (Sigma), followed by centrifugation for 1 h at 990 g and 321C. Spin transduction was repeated once after 24 h. After transduction, cells were selected for 3 days in IMDM medium supplemented with IL3, IL6 and SCF plus G418 (1.4 mg/ml). Starting at the first day post selection, cells were cultured in IMDM medium supplemented either with IL3, IL6 and SCF or with GM-CSF and IL3, as indicated. Cell cultures were maintained at a concentration of ca 2.5 Â 10 5 cells/ml by replating cells in fresh medium every second day. Transduction of K562 cells was carried out as described for bone marrow cells.
Methylcellulose cultures
Cells were seeded in 1 ml methylcellulose solution (MethoCult M31134, Stem Cell Tech.) containing 30% FCS, 1% BSA, 10 À4 M 2-ME, 10 ng/ml rmIL3 (PeproTech) and 2% pokeweed mitogen, murine spleen-cell conditioned medium (PWM-SCCM, Stem Cell Tech.). After 7 days of culture under G418 selection (1.4 mg/ml) primary colonies were counted, harvested and the mean cell number per colony calculated. After reseeding, secondary colonies were counted after another 11 days of culture.
Mice
C57Bl/6 CD45.1 bone marrow donor mice were 6-10 weeks of age and recipient mice (C57Bl/6 CD45.2) were 10-12 weeks old. Animals were either bought from Charles River (Sulzfeld, Germany) or bred and housed at the mouse facility of the MSZ, Wu¨rzburg. All animal handling was carried out according to the animal protection guidelines of the government of Unterfranken, Wu¨rzburg, Germany.
Transplantation of bone marrow cells
Recipient mice were irradiated with 11.5 Gray (split dose, 137 Cs-Gammatron, 0.511 MeV, dose rate ¼ 0.322 Gray/min). In total, 5 Â 10 5 infected CD45.1 bone marrow cells were injected into transplant recipients together with 2 Â 10 5 freshly isolated competitive CD45.2 bone marrow cells. Transplant recipients were treated with neomycin sulphate (Applichem) via the drinking water for 2 days prior to irradiation and until 4 weeks after. Chimerism in the peripheral blood of transplant recipients was determined by flow cytometric analysis for CD45.1 þ donor cells.
H-thymidine incorporation
To evaluate proliferation of HOXB4-transduced bone marrow cells, 5 Â 10 4 cells were plated in 200 ml IMDM medium supplemented with growth factors. Starting at 4 dpt, cells were labelled with 3 H-thymidine (2 mCi/ml) for 16 h prior to harvesting onto glass fiber filters (Harvester, Wallac). Thymidine incorporation was quantified by liquid scintillation counting (Wallac).
Flow cytometry and analysis of cell morphology
For CFSE (5-and 6-carboxyfluorescein diacetate succinimidyl ester) labelling 4 Â 10 6 bone marrow cells were resuspended in 
RNase protection assays
Total RNA was isolated using the RNeasy Mini Kit (Qiagen). Samples of 5 mg RNA each were hybridized with one of the following template sets: mCYC-1, mCYC-2, mCC-1 and mFos/Jun (BD Pharmingen). RNase protection assays were performed according to the manufacturer's protocol (BD Pharmingen). mRNA levels were normalized to the housekeeping gene transcripts L32 and GAPDH.
Western blot analysis
For Western blot analysis, whole-cell lysates were prepared from K562 cells with RIPA lysis buffer (50 mM Tris-HCl, pH 7.8, 1% NP-40, 0.25% NaDOC, 150 mM NaCl, 1 mM EDTA, 2 mM NaF, 0.002% NaN 3 ) supplemented with proteinase inhibitors and DTT. The protein content was quantified using quantiPro BCA assay kit (SigmaAldrich). Equal protein amounts were electrophoretically separated on a 10% SDS-PAA gel and electro-transferred onto nitrocellulose membranes. After blocking with 5% skim milk, membranes were probed with anti-HA mAb, washed, and incubated with horseradish peroxidase-conjugated secondary antibody. Membranes were developed using ECL reagents (Amersham Biosciences). After stripping of membranes, equal loading of the lanes was verified with primary anti-actin mAb.
